Novonesis to invest in manufacturing expansion in MaharashtraIllustrative image – not actual.

Novonesis is set to invest 600 million to significantly expand its Patalganga facility in Maharashtra, positioning the site as a major manufacturing hub for India, South Asia, the Middle East and Africa.

The expansion is expected to nearly quadruple the facility’s existing capacity and will be implemented in phases through 2030. Novonesis describes the Patalganga site as one of the world’s most advanced enzyme-production facilities, and will also make its global supply network more flexible and resilient. The project comes as the company accelerates capital expenditure globally. Its net investments, excluding acquisitions, increased 81 percent to 215.7 million in the first half.

The investment commitment highlights the strategic importance of India in the company's emerging-markets growth plans. Maharashtra expansion is a key part of its long-term manufacturing and supply-chain strategy.


← All latest storiesBack to top →